Children's Oncology Group's 2013 blueprint for research: Adolescent and young adult oncology

Pediatric Blood and Cancer

Volumn 60, Issue 6, 2013, Pages 1055-1058

  Freyer, David R ^a   Felgenhauer, Judy ^b   Perentesis, John ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Providence Sacred Heart Hospital   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Adolescent cancers; AYA; AYA patients; Childhood cancer; Toxicity

Indexed keywords

CANCER RESEARCH; CANCER SURVIVAL; CHILDHOOD CANCER; FOLLOW UP; GROUPS BY AGE; HEALTH SERVICE; HUMAN; PRIORITY JOURNAL; REVIEW; UNITED STATES;

ADOLESCENT; CLINICAL TRIALS AS TOPIC; COOPERATIVE BEHAVIOR; DELIVERY OF HEALTH CARE; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; RESEARCH; YOUNG ADULT;

EID: 84876422594     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24431     Document Type: Review

References (21)

1. Adolescent and Young Adult Oncology Progress Review Group. Closing the gap: Research and care imperatives for adolescents and young adults with cancer. Report of the Adolescent and Young Adult Progress Review Group.: US Department of Health and Human Services, National Institutes of Health, National Cancer Institute and LiveStrong Young Adult Alliance; 2006. Available from: http://planning.cancer.gov/library/AYAO_PRG_Report_2006_FINAL.pdf
2. NCI Cancer Bulletin. 2011 [updated 2011; cited 2012 June 5]; Available from: http://www.cancer.gov/ncicancerbulletin/072611/
3. Burke ME, Albritton K, Marina N. Challenges in the recruitment of adolescents and young adults to cancer clinical trials. Cancer 2007; 110: 2385-2393.
4. Freyer DR. Transition of care for young adult survivors of childhood and adolescent cancer: Rationale and approaches. J ClinOncol 2010; 28: 4810-4818.
5. Barr R, Eden T. International working group on adolescent/teenage and young adult oncology. Pediatr Blood Cancer 2008; 50: 1089.
6. McNeer JL, Raetz EA. Acute lymphoblastic leukemia in young adults: which treatment? Curr Opin Oncol 2012; 24: 487-494.
7. Khamly KK, Thursfield VJ, Fay M, et al. Gender-specific activity of chemotherapy correlates with outcomes in chemosensitive cancers of young adulthood. Int J Cancer 2009; 125: 426-431.
8. Janeway KA, Barkauskas DA, Krailo MD, et al. Outcome for adolescent and young adult patients with osteosarcoma: A report from the Children's Oncology Group. Cancer 2012; 118: 4597-4605.
9. Albritton K, Krailo M, Marina NM, et al. Older age as an independent prognostic factor in Ewing sarcoma treated on Children's Oncology Group protocols. Poster presentation at Connective Tissue Oncology Society 2012 Annual Meeting.
10. Fernandez KS, Chen L, Schwartz C, et al. Survival in adolescents and young adults with Hodgkin lymphoma treated with response-based chemotherapy on P9425 and P9426 protocols: A report from the Children's Oncology Group. Blood 2011; 118: 44.
11. Franklin ARK, Alonzo TA, Gerbing RB, et al. Outcome of adolescents and young adults (AYAs) with non-M3 acute myeloid leukemia (AML) treated on Children's Oncology Group (COG) trials compared to Cancer and Leukemia Group B (CALGB) and Southwest Oncology Group (SWOG) trials. Blood 2011; 116: 84.
12. Canner J, Alonzo T, Franklin J, et al. Treatment outcomes in older adolescent and young adult (AYA) patients with newly diagnosed AML. Oral presentation at American Society of Clinical Oncology 2011 Annual Meeting.
13. Gupta AA, Anderson JR, Pappo AS, et al. Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Cancer 2012; 118: 1130-1137.
14. Langholz B, Skolnik JM, Barrett JS, et al. Dactinomycin and vincristine toxicity in the treatment of childhood cancer: A retrospective study from the Children's Oncology Group. Pediatr Blood Cancer 2011; 57: 252-257.
15. Raetz E, Devidas M, Carroll A, et al. Cytogenetic and early response characteristics of adolescents and young adults with acute lymphoblastic leukemia: A Children's Oncology Group study. Oral presentation at American Society of Clinical Oncology 2010 Annual Meeting.
16. Larsen EC, Salzer W, Nachman J, et al. Treatment Toxicity in adolescent and young adult (AYA) patients compared with younger patients treated for high risk B-precursor acute lymphoblastic leukemia (HR-ALL): A report from the Children's Oncology Group study AALL0232. Blood 2011; 118: 655.
17. Larsen E, Devidas M, Raetz E, et al. Outcome in adolescent and young adult (AYA) patients compared with younger patients treated for high risk B-precursor acute lymphoblastic leukemia (HR-ALL): A report from the Children's Oncology Group study AALL0232. Oral presentation at American Society of Clinical Oncology 2012 Annual Meeting.
18. Eshelman-Kent D, Kinahan KE, Hobbie W, et al. Cancer survivorship practices, services, and delivery: A report from the Children's Oncology Group (COG) nursing discipline, adolescent/young adult, and late effects committees. J Cancer Surviv 2011; 5: 345-357.
19. NCI AYA website. Available from: http://www.cancer.gov/cancertopics/aya.
20. Barr R, Rogers P, Schacter B. Adolescents and young adults with cancer: Towards better outcomes in Canada. Cancer 2011; 117: 2239-2240.
21. Fernandez C, Fraser G, Freeman C, et al. Principles and recommendations for the provision of healthcare in Canada to adolescent and young adult-aged cancer patients and survivors. J Adolesc Young Adult Oncol 2011; 1: 53-59.